BSE
Your Result on : Company News Details
Indraprastha Medical Corporation Ltd Industry :  Healthcare
BSE Code
532150
ISIN Demat
INE681B01017
Book Value (Rs)
88.8410983
NSE Symbol
INDRAMEDCO
Divident Yield %
1.21
Market Cap
(Rs In Cr.)
3,028
P/E (TTM)
15.76
EPS (TTM)
20.96
Face Value
(Rs)
10
Back
Indraprastha Medical Corporation standalone net profit rises 8.33% in the September 2026 quarter
30-Oct-26   Hrs IST

Net profit of Indraprastha Medical Corporation rose 8.33% to Rs 53.58 crore in the quarter ended September 2026 as against Rs 49.46 crore during the previous quarter ended September 2025. Sales rose 8.35% to Rs 412.85 crore in the quarter ended September 2026 as against Rs 381.03 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales412.85381.03 8
OPM %18.7618.72 -
PBDT84.3377.17 9
PBT72.0766.31 9
NP53.5849.46 8

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)